Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 USD | -2.46% | -9.63% | +128.38% |
05-02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+128.38% | 155M | |
+65.03% | 62.59B | |
-1.23% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.34% | 26.21B | |
-21.77% | 19.09B | |
+4.87% | 13.08B | |
+25.53% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- Transcript : Cardiff Oncology, Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-18-2023 01